-- 
Colfax, Investors, Johnson & Johnson, Merck: U.S. Equity Preview

-- B y   I n y o u n g   H w a n g
-- 
2011-09-09T21:10:05Z

-- http://www.bloomberg.com/news/2011-09-09/colfax-investors-johnson-johnson-merck-u-s-equity-preview.html
Shares of the following companies
may have unusual moves in U.S. trading on Sept. 12. Stock
symbols are in parentheses.  Colfax Corp. (CFX)  : Charter International Plc is close
to accepting a bid from the Fulton, Maryland-based manufacturer
of pumps and specialty valves, the Daily Telegraph reported,
citing unnamed sources.  Investors Real Estate Trust (IRET)  : The Minot, North
Dakota-based real estate investment trust reported funds from
operations in the first quarter were 16 cents a share, matching
the average analyst estimate.  Johnson & Johnson (JNJ)  : The worldâ€™s second-biggest
maker of health-care products failed to win U.S. clearance for
wider use of Simponi, a two-year-old arthritis drug.  Merck & Co. (MRK US): The second-largest U.S. drugmaker,
Warner Chilcott Plc, Roche Holding AG and Novartis AG should add
clarifications on the length of time that osteoporosis patients
may take their bone drugs to reduce the risk of fractures,
outside advisers to the  Food and Drug Administration  said.  To contact the reporter on this story:
Inyoung Hwang in New York at 
 ihwang7@bloomberg.net .  To contact the editor responsible for this story:
Nick Baker at   nbaker7@bloomberg.net . 